Trial intelligence / Profile preview

Safety and PK of Multiple Oral Doses of IX-01 in Healthy Men

NCT02792647Phase 1Completed

Sponsor
Ixchelsis
Start
May 2016
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in premature ejaculation (PE) comparing Placebo with IX-01 (2 arms). Primary endpoint: Number of Participants with One or More Drug Related Adverse Events (AEs) or any Serious AEs. Started May 2016; status: completed.

02

Drugs

cligosiban
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT02792647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02792647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call